B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis
Individuals receiving anti-VEGF treatments should target an optimal cardiovascular health profile, which includes low-density lipoprotein (LDL) levels below 100 mg/dL, fasting glucose between 80 - 86 mg/dL, etc
Similarly, the FSDS-DAO, which measures sexual distress with lower scores reflecting less distress, demonstrated a greater reduction in scores among BMT-treated women, with an average decrease of 11.1 points, versus a 6.8-point decrease in placebo recipients
Additional factors, including the patients age, medical history, and lifestyle choices, can also impact its effectiveness in achieving the desired weight goals
This article breaks down the science, clinical trial results, and real-world experiences with these medications to help you understand their role in weight loss